Medaglia, A., Cohen, A., Lee, H., Trudel, S., Abdallah, A., Callander, N., . . . Opalinska, J. (2020). Impact of prolonged dose delays on response with belantamab mafodotin (belamaf; gsk2857916) treatment in dreamm-2 study: 13-month follow-up. MDPI AG.
Chicago Style (17th ed.) CitationMedaglia, A., et al. Impact of Prolonged Dose Delays on Response with Belantamab Mafodotin (belamaf; Gsk2857916) Treatment in Dreamm-2 Study: 13-month Follow-up. MDPI AG, 2020.
MLA (9th ed.) CitationMedaglia, A., et al. Impact of Prolonged Dose Delays on Response with Belantamab Mafodotin (belamaf; Gsk2857916) Treatment in Dreamm-2 Study: 13-month Follow-up. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.